Optos AMD Solutions

 

Find Out More

 

Early detection of age-related macular degeneration (AMD) offers an
opportunity to intervene early in the course of disease.

Our unique program is aimed at preventing vision loss due to dry AMD. Using new technology to find, test and treat, the program offers patients with dry AMD the hope of years of good vision.

Optos AMD Solutions is based on three powerful technologies:

 

AMD Solutions

Identifying AMD early

If one of your relatives (parent, siblings) is diagnosed with AMD, and you are +40 yrs, it’s recommended to have a regular annual eye exam. AdaptDx Pro by MacuLogix is a revolutionary way to test patients. It is the only test for dark adaptation that can be used in any clinical setting quickly and effectively and does not require a dark room.

Find and document AMD with ultra-wide field imaging

Ultra-widefield imaging has been shown to contribute to the benefits in the diagnosis and management of AMD. Studies have shown that AMD may be more than a “macular” condition but one that involves the entire retina.

Valeda Light Delivery System to treat

The Valeda Light Delivery System is the first and only approved treatment for dry AMD using photobiomodulation (PBM), creating a brighter horizon for patients by developing treatment solutions to improve visual function, stop or slow the progression of debilitating eye diseases and prevent vision loss and blindness.



AdaptDx ProTM  Guided by TheiaTM

Diagnosing age-related macular degeneration (AMD) at its earliest subclinical stage allows you to proactively slow progression of the disease with intervention strategies. 

Dark adaptation testing with the AdaptDx Pro guided by Theia:

Highly accurate – 90.6% sensitive to identifying AMD cases and 90.5% specific to identifying normal cases.

Subclinical detection – helps you diagnose AMD at least three years before drusen are clinically visible

Scientifically proven – backed by over 40 peer-reviewed publications

AdaptDx Pro combines the game-changing science of dark adaptation
testing with patient comfort and convenience.

Learn More

 

AdaptDx Pro Brochure

optomap® Ultra-widefield Retinal Imaging

Ultra-widefield imaging has been shown to contribute to the benefits in the diagnosis and management of AMD.

Using ultra-widefield optomap colour and autofluorescence retinal images as part of your comprehensive ocular health. In partnership with AdaptDX Pro, and Valeda, Optos has created a new program aimed at preventing vision loss due to Dry AMD.

Using new technology to find, test, and treat dry AMD this program offers patients with Dry AMD the hope of years of good vision.

 

 

 

 

 

 

 

The Benefits of optomap

How an optomap image is captured

AMD case study

A Vision for a Brighter Future

ValedaTM Light Delivery System

First approved treatment for Dry Age-Related Macular Degeneration using photobiomodulation.

Valeda was designed for ease of use in the doctor’s surgery

Under the doctor’s supervision, trained staff are able to administer the Valeda treatment.

  • Excellent safety profile
  • Preserves future treatment options

Treatments are delivered in a series of 9 sessions per eye over a three-week period. Each treatment session lasts less than 5 minutes per eye.

Valeda is a platform with the potential to successfully treat a number of degenerative ocular diseases.

 

Learn More

Valeda Brochure

Introducing Valeda Light Delivery System

Would you like to know more? Please complete the form below and a member of our team will be in touch shortly.